1.77
1.14%
0.02
Finanzdaten der Iterum Therapeutics Plc-Aktie (ITRM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
46.09%
6.163
|
11.43 | 16.68 | 10.82 | 8.53 |
Operating Income/Loss |
46.09%
-6.163
|
-11.43 | -16.68 | -10.82 | -8.53 |
Nonoperating Income/Loss |
12.80%
-0.89
|
-0.789 | 12.97 | -1.234 | -1.236 |
Income/Loss From Continuing Operations Before Tax |
42.28%
-7.053
|
-12.22 | -3.716 | -12.06 | -9.766 |
Income Tax Expense/Benefit |
66.20%
0.048
|
0.142 | 0.161 | 0.187 | 0.123 |
Income/Loss From Continuing Operations After Tax |
42.56%
-7.101
|
-12.36 | -3.877 | -12.24 | -9.889 |
Net Income/Loss
|
42.56%
-7.101
|
-12.36 | -3.877 | -12.24 | -9.889 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
20,899%
15.43
|
0.0735 | 13.04 | 12.94 | 12.68 |
Diluted Average Shares |
20,899%
15.43
|
0.0735 | 13.04 | 12.94 | 12.68 |
Basic Earnings Per Share |
51.06%
-0.46
|
-0.94 | -0.30 | -0.95 | -0.78 |
Diluted Earnings Per Share |
51.06%
-0.46
|
-0.94 | -0.30 | -0.95 | -0.78 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):